Compare Stocks: ZTS vs. VTRS vs. PBH vs. IRWD
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
ZTSVTRSPBHIRWD
Market Snapshot
Current market context for the selected companies.
ZTS
$77.15
Market Cap
$32.12B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Data through
2026-08-24
VTRS
$16.54
Market Cap
$18.75B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Data through
2026-08-24
PBH
$52.05
Market Cap
$2.43B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Data through
2026-08-24
IRWD
$4.12
Market Cap
$708.88M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Data through
2026-08-24
Performance
Absolute returns and relative performance versus SPY.
| Metric | ZTS | VTRS | PBH | IRWD |
|---|---|---|---|---|
| 1 Month | +2.4% | -4.1% | +4.8% | +11.2% |
| 1 Month vs SPY | -0.9% | -7.4% | +1.5% | +7.9% |
| 3 Months | -5.1% | -0.7% | +8.4% | +5.2% |
| 3 Months vs SPY | -7.5% | -3.0% | +6.1% | +2.8% |
| 6 Months | -38.7% | +3.7% | -25.3% | +10.0% |
| 6 Months vs SPY | -50.5% | -8.2% | -37.2% | -1.9% |
| 1 Year | -50.4% | +54.7% | -20.5% | +249.6% |
| 1 Year vs SPY | -70.5% | +34.6% | -40.6% | +229.5% |
| 2 Years | -58.2% | +39.8% | -24.8% | -13.3% |
| 2 Years vs SPY | -94.6% | +3.4% | -61.3% | -49.8% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.